Stock Events

Stock Events

Neuroscientific Biopharmaceuticals 

A$0.061000
4
-A$0.00-6.15% Thursday 04:32

Statistics

Day High
0.064
Day Low
0.061
52W High
0.19
52W Low
0.055
Volume
41,005
Avg. Volume
275,908
Mkt Cap
23.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26JulExpected
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q4 2023
Q2 2024
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-1.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NSB.AU. It's not an investment recommendation.
Brainchip
2
BRN.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurodegenerative diseases, similar to NSB's focus on neurological disorders.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong portfolio in Alzheimer's disease treatments, directly competing with NSB's Alzheimer's projects.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG has significant investments in neuroscience and Alzheimer's disease, overlapping with NSB's research areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a history of developing treatments for neurological conditions, competing in the same therapeutic area as NSB.
Novartis
NVS
Mkt Cap292.35B
Novartis offers several products for neurological conditions, making it a direct competitor in the neurology sector.
Merck
MRK
Mkt Cap366B
Merck & Co. is involved in developing therapies for Alzheimer's disease, which is a key area for NSB.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie has a growing interest in neurodegenerative diseases, particularly Alzheimer's, competing with NSB's focus.
AMGEN
AMGN
Mkt Cap233.78B
Amgen has research initiatives in neuroscience, including Alzheimer's disease, positioning it as a competitor to NSB.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson conducts extensive research in neuroscience, making it a competitor in the neurological space.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca has a dedicated neuroscience R&D unit, which competes with NSB in developing neurological disorder treatments.

About

Established in 2002 and headquartered in Cottesloe, Australia, NeuroScientific Biopharmaceuticals Limited specializes in the development of medical therapies for neurodegenerative conditions. The company conducts extensive preclinical and clinical research utilizing its proprietary technological platforms to advance these treatments. Its primary pharmaceutical compound, EmtinB, is being developed as a potential therapeutic agent for diseases including neurodegenerative dementia, Alzheimer's disease, and various degenerative disorders affecting the optic nerve.
Show more...
CEO
Nathan Smith
Employees
9
Country
Australia
ISIN
AU0000012973

Listings

AU
AU
NSB.AU

0 Comments

Share your thoughts

FAQ

What is Neuroscientific Biopharmaceuticals stock price today?▼
The current price of NSB.AU is A$0.06 AUD — it has decreased by -6.15% in the past 24 hours. Watch Neuroscientific Biopharmaceuticals stock price performance more closely on the chart.
What is Neuroscientific Biopharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Neuroscientific Biopharmaceuticals stocks are traded under the ticker NSB.AU.
Is Neuroscientific Biopharmaceuticals stock price growing?▼
NSB.AU stock has fallen by -1.61% compared to the previous week, the month change is a -1.61% fall, over the last year Neuroscientific Biopharmaceuticals has showed a -64.12% decrease.
What is Neuroscientific Biopharmaceuticals market cap?▼
Today Neuroscientific Biopharmaceuticals has the market capitalization of 23.77M
What is Neuroscientific Biopharmaceuticals revenue for the last year?▼
Neuroscientific Biopharmaceuticals revenue for the last year amounts to 0 AUD.
What is Neuroscientific Biopharmaceuticals net income for the last year?▼
NSB.AU net income for the last year is -1.85M AUD.
How many employees does Neuroscientific Biopharmaceuticals have?▼
As of September 04, 2026, the company has 9 employees.
In which sector is Neuroscientific Biopharmaceuticals located?▼
Neuroscientific Biopharmaceuticals operates in the Health & Wellness sector.
When did Neuroscientific Biopharmaceuticals complete a stock split?▼
Neuroscientific Biopharmaceuticals has not had any recent stock splits.
Where is Neuroscientific Biopharmaceuticals headquartered?▼
Neuroscientific Biopharmaceuticals is headquartered in Perth, Australia.